GENERIC MEDICINE
IP/LEGAL &
REGULATORY ISSUES

Conference Date: 21 Sep 2009
Conference Ref: A9-4109
Fee: £545 + VAT
Venue: The Rembrandt Hotel, London

It is often difficult for those involved in marketing generic medicines to understand the complicated legal and regulatory environment in which they operate. Similarly, regulatory people themselves are often unsure how the legal and Intellectual Property framework can influence their own work.

The aim of this seminar is to shed some light on the legal background to the generic industry and to provide an understanding of how it affects all parts of the industry. Misunderstanding the various factors that influence the time and speed of registration can lead to regulatory delays with a knock-on effect on launch dates for new products. This can in turn lead to undesirable delays, which might have an impact on a company’s competitive position.

With Peter Wittner Interpharm

Benefits of Attending:

• Better Understand the European Generics Marketplace
• Gain an overview of IP issues and their Importance to the Generics Industry
• Receive an Update on new Directive 2004/27/EC and the Changes that it has Introduced
• Discuss the Interplay between Regulatory and Commercial Aspects of Generics
• Compare the US Environment & Europe

To book your place on this important event, please click here.